World Wealth Journal
SEE OTHER BRANDS

Bringing you the latest news on finance and banking

World Wealth Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wealth Journal.

Press releases published on May 18, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF

Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bitfarms Ltd. ("Bitfarms" or the "Company") (NASDAQ: BITF) and certain officers. The class action, filed in the United States District …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Open Lending Corporation of Class Action Lawsuit and Upcoming Deadlines - LPRO

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Open Lending Corporation of Class Action Lawsuit and Upcoming Deadlines - LPRO

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Open Lending Corporation. (“Open Lending” or the “Company”) (NASDAQ: LPRO).   Such investors are advised to contact Danielle Peyton at  …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Backblaze, Inc. - BLZE

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Backblaze, Inc. - BLZE

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Backblaze, Inc. (“Backblaze” or the “Company”) (NASDAQ: BLZE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646 …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA).  Such investors are advised to contact Danielle Peyton at newaction@ …

IOVA Investors Have the Opportunity to Lead the Iovance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

IOVA Investors Have the Opportunity to Lead the Iovance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi …

LPRO Investors Have the Opportunity to Lead the Open Lending Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

LPRO Investors Have the Opportunity to Lead the Open Lending Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi …

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

 Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10MWRT and CMT-FOM …

Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting

Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting

Deep, durable and consistent reductions in TTR were sustained at two years, following a one-time dose of nex-z Clinically meaningful improvements in ATTRv-PN related outcomes observed at 24 months compared to baseline, including in patients who were …

Bitcoin Solaris Unveils Hybrid Consensus Architecture Ahead of Nova App Mining Launch

Bitcoin Solaris Unveils Hybrid Consensus Architecture Ahead of Nova App Mining Launch

TALLINN, Estonia, May 18, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris is officially unveiling its advanced hybrid consensus architecture, purpose-built to support fast, decentralized applications with user-integrated mining and sub-2-second finality. This …

ZA Miner bietet passive Einkommensmöglichkeiten mit Kryptowährungen und flexiblen Verträgen

ZA Miner bietet passive Einkommensmöglichkeiten mit Kryptowährungen und flexiblen Verträgen

ZA Miner-Bild MIDDLESEX, Vereinigtes Königreich, May 18, 2025 (GLOBE NEWSWIRE) -- Als Reaktion auf das wachsende Interesse am Mining digitaler Vermögenswerte hat ZA Miner eine optimierte Infrastruktur eingeführt, die Nutzern zugängliche und sichere …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service